Myriad Genetics
  • Patients
    • I need help with…
      • Understanding hereditary cancer riskWhat is my risk of developing hereditary cancer?
      • Treating cancerWhat are my treatment options?
      • Guiding prenatal careAm I having a boy or girl?
        • Is my baby at risk for a genetic condition?
      • Managing mental healthHow might my genes affect my medication outcomes?
    • (sidebar parent)
      • About genetic testing
        • Affordability
        • Financial assistance
      • Patient Resources
        • How does genetic testing work?
        • Patient record request
        • Documents & forms
        • Blood draw locator
        • Blog
      • Prostate Cancer
        • What are my treatment options?
  • Providers
    • My patient needs a test for…
      • Assessing hereditary cancer riskWhat is my patient’s risk of developing hereditary cancer?
      • Cancer treatmentWhat is the best treatment for my patient?
      • Prenatal careWhat is the predicted fetal sex of my patient’s baby?
        • What is a pregnancy’s risk of a genetic disease?
      • Mental health treatmentHow will my patient metabolize or respond to certain medications?
    • (sidebar parent)
      • About our tests
        • Myriad test catalog
        • Scientific Publications
        • MyRisk® gene table
        • Affordability
        • Financial assistance
        • EMR Integrations
      • Provider resources
        • Order a test kit
        • Order patient materials
        • Documents & forms
        • Scope of service & lab certificates
        • Provider portal
        • Blood draw locator
        • Blog
        • Webinars & events
      • Prostate Cancer Treatment
        • What are my patient’s treatment options?
      • Health Systems
        • Women’s Health
  • Biopharma
  • Our Tests
    • Tests for…
      • (column wrapper)
        • Prenatal care
          • Fetal sex
          • Chromosome conditions
          • Genetic diseases
        • Cancer risk assessment
          • Hereditary cancer
        • Mental health
          • Depression
          • Anxiety
          • ADHD
      • (column wrapper)
        • Cancer management
          • Breast cancer
          • Ovarian cancer
          • Pancreatic cancer
          • Prostate cancer
          • Endometrial cancer
          • Other cancers
          • All tests
    • (sidebar parent)
      • TESTS BY SPECIALTY
        • Oncology
        • Urology
        • Imaging
        • OB/GYN
        • Mental Health
        • Internal/Primary care
        • All tests
      • TESTS BY NAME
        • BRACAnalysis CDx®
        • EndoPredict®
        • FirstGene™
        • Foresight®
        • GeneSight®
        • MyChoice® CDx
        • MyRisk® (cancer treatment)
        • MyRisk® (cancer risk)
        • Prequel®
        • Precise Tumor®
        • Prolaris®
        • SneakPeek®
  • About
    • About
      • (column wrapper)
        • About Myriad
        • Leadership
        • Investor relations
        • Newsroom
      • (column wrapper)
        • Webinars & events
        • Careers
        • Contact
    • (sidebar parent)
      • Myriad Genetics Laboratory and Support Center
        • 322 North 2200 West
        • Salt Lake City, UT 84116
        • Corporate Phone: (801) 584-3600
        • Corporate Fax: (801) 584-3640
PORTALS ORDER
    Portals
    Order
  • Patients
    • I need help with…
      • Understanding hereditary cancer riskWhat is my risk of developing hereditary cancer?
      • Treating cancerWhat are my treatment options?
      • Guiding prenatal careAm I having a boy or girl?
        • Is my baby at risk for a genetic condition?
      • Managing mental healthHow might my genes affect my medication outcomes?
    • (sidebar parent)
      • About genetic testing
        • Affordability
        • Financial assistance
      • Patient Resources
        • How does genetic testing work?
        • Patient record request
        • Documents & forms
        • Blood draw locator
        • Blog
      • Prostate Cancer
        • What are my treatment options?
  • Providers
    • My patient needs a test for…
      • Assessing hereditary cancer riskWhat is my patient’s risk of developing hereditary cancer?
      • Cancer treatmentWhat is the best treatment for my patient?
      • Prenatal careWhat is the predicted fetal sex of my patient’s baby?
        • What is a pregnancy’s risk of a genetic disease?
      • Mental health treatmentHow will my patient metabolize or respond to certain medications?
    • (sidebar parent)
      • About our tests
        • Myriad test catalog
        • Scientific Publications
        • MyRisk® gene table
        • Affordability
        • Financial assistance
        • EMR Integrations
      • Provider resources
        • Order a test kit
        • Order patient materials
        • Documents & forms
        • Scope of service & lab certificates
        • Provider portal
        • Blood draw locator
        • Blog
        • Webinars & events
      • Prostate Cancer Treatment
        • What are my patient’s treatment options?
      • Health Systems
        • Women’s Health
  • Biopharma
  • Our Tests
    • Tests for…
      • (column wrapper)
        • Prenatal care
          • Fetal sex
          • Chromosome conditions
          • Genetic diseases
        • Cancer risk assessment
          • Hereditary cancer
        • Mental health
          • Depression
          • Anxiety
          • ADHD
      • (column wrapper)
        • Cancer management
          • Breast cancer
          • Ovarian cancer
          • Pancreatic cancer
          • Prostate cancer
          • Endometrial cancer
          • Other cancers
          • All tests
    • (sidebar parent)
      • TESTS BY SPECIALTY
        • Oncology
        • Urology
        • Imaging
        • OB/GYN
        • Mental Health
        • Internal/Primary care
        • All tests
      • TESTS BY NAME
        • BRACAnalysis CDx®
        • EndoPredict®
        • FirstGene™
        • Foresight®
        • GeneSight®
        • MyChoice® CDx
        • MyRisk® (cancer treatment)
        • MyRisk® (cancer risk)
        • Prequel®
        • Precise Tumor®
        • Prolaris®
        • SneakPeek®
  • About
    • About
      • (column wrapper)
        • About Myriad
        • Leadership
        • Investor relations
        • Newsroom
      • (column wrapper)
        • Webinars & events
        • Careers
        • Contact
    • (sidebar parent)
      • Myriad Genetics Laboratory and Support Center
        • 322 North 2200 West
        • Salt Lake City, UT 84116
        • Corporate Phone: (801) 584-3600
        • Corporate Fax: (801) 584-3640

Category: Prolaris

Prolaris
  • Category
    • All
    • About Myriad Genetics
    • Breast Cancer
    • Carrier screening
    • Colorectal Cancer
    • Corporate
    • Employee Spotlight
    • Equity
    • GeneSight
    • Genetic Counselors
    • Health Systems
    • Hereditary Cancer
    • Infographic for Multimedia page
    • Infographics
    • Lynch Syndrome
    • Melanoma
    • MyRisk
    • Neuroscience
    • Oncology
    • Ovarian Cancer
    • Pancreatic Cancer
    • Patient Blog
    • Patient Story
    • Patient-Featured
    • Prenatal care
    • Prenatal Screening (NIPS)
    • Prequel
    • Prolaris
    • Prostate Cancer
    • Provider Blog
    • Uncategorized
    • Urology
    • Women's Health

How Genomic Testing is Transforming Treatment Decisions in Intermediate-Risk Prostate Cancer

September 4, 2025

By Lauren Lenz, Christina Nakamoto, & Robert Finch In men with prostate cancer, few decisions are as difficult—or as emotionally charged—as choosing...

Continue Reading

Precision Medicine in Prostate Cancer: How Genetic Testing Makes a Difference

December 15, 2021

Back when scientists sequenced a human genome for the first time — a years-long project that took billions of dollars — they were in part motivated by the p...

Continue Reading

Genetic Testing Can Help Men with Prostate Cancer Receive the Right Treatment

September 1, 2018

September is Prostate Cancer Awareness Month. According the American Cancer Society, more than 165,000 men will be diagnosed with prostate cancer this year, and...

Continue Reading

Men’s Health Month and Myriad’s Prolaris Test

June 12, 2017

June is Men’s Health Month and it’s important to help generate awareness on education for early detection of Men’s health issues, such as prostate cance...

Continue Reading
  • Managed care
    • Payers
  • Investors
    • Investor relations
  • News
    • Newsroom
    • Blog
  • About
    • About Myriad
    • Careers
    • Contact us
  • Terms of Use
  • HIPAA Notice of Privacy Practices
  • Provider Portal Terms of Use
  • Privacy Notice
  • Patents
  • Health Privacy Notice
  • Compliance and Code of Conduct
  • Notice of Nondiscrimination and Discrimination Grievance Procedure
  • IT Security
  • Notice of Access to Language Assistance Services
  • Cookie Preferences
facebook linkedin x X/Twitter social network instagram youtube
  • © 2025 Myriad Genetics, Inc.

Locations

United States
Europe
Japan